A Pharmacodynamics Pre-surgical Study of LEE011 in Early Breast Cancer Patients (MONALEESA-1)

NCT01919229 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

INDUSTRY

Sponsor class

Stopped Due to low recruitment, it was decided to terminate the study.

Conditions

Early Breast Cancer

Interventions

DRUG: LEE011 (ribociclib)
DRUG: letrozole

Sponsor

Novartis Pharmaceuticals